Medication adherence and asthma control with once-daily indacaterol/glycopyrronium/mometasone (IND/GLY/MF) Breezhaler(R) digital companion: interim analysis from Europe

Conclusions: Pts using Breezhaler® digital companion showed good medication adherence (≥92% over 6 months) which did not decline over time and improved asthma control. Long-term studies may be required to confirm these findings.

Source: European Respiratory Journal - December 1, 2022 Category: Respiratory Medicine Authors: Woehrle, H., Mastoridis, P., A Stempel, D., Kaye, L., Vuong, V., Mezzi, K. Tags: 05.01 - Airway pharmacology and treatment Source Type: research